{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T20:19:18Z","timestamp":1787861958404,"version":"build-2784847793"},"reference-count":55,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100002742","name":"Banaras Hindu University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002742","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","award":["IIRP2023-0227"],"award-info":[{"award-number":["IIRP2023-0227"]}],"id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","award":["IIRP-2023-5195"],"award-info":[{"award-number":["IIRP-2023-5195"]}],"id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004541","name":"Ministry of Education, India","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004541","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001843","name":"Science and Engineering Research Board","doi-asserted-by":"publisher","award":["CRG\/2023\/003559"],"award-info":[{"award-number":["CRG\/2023\/003559"]}],"id":[{"id":"10.13039\/501100001843","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.bioorg.2025.108718","type":"journal-article","created":{"date-parts":[[2025,7,3]],"date-time":"2025-07-03T10:08:39Z","timestamp":1751537319000},"page":"108718","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Targeting drug-resistant tuberculosis: Thioacetamide-substituted benzothiazoles as bactericidal agents inhibiting type II NADH dehydrogenase"],"prefix":"10.1016","volume":"163","author":[{"given":"Pallavi","family":"Saha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shashikanta","family":"Sau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nitin Pal","family":"Kalia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepak K.","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioorg.2025.108718_bb0005","doi-asserted-by":"crossref","first-page":"16076","DOI":"10.1038\/nrdp.2016.76","volume":"2","author":"Pai","year":"2016","journal-title":"Tuberculosis Nat. Rev. Dis. Primers."},{"key":"10.1016\/j.bioorg.2025.108718_bb0010","series-title":"World Health Organization Global Tuberculosis Report 2022","year":"2022"},{"key":"10.1016\/j.bioorg.2025.108718_bb0015","series-title":"Geneva: World Health Organization; 2023 Global Tuberculosis Report 2023","first-page":"2023","author":"Global tuberculosis report","year":"2023"},{"issue":"2021","key":"10.1016\/j.bioorg.2025.108718_bb0020","first-page":"S7","article-title":"Reflections on the global TB burden, treatment and prevention efforts Int","volume":"113","author":"Chakaya","year":"2020","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.bioorg.2025.108718_bb0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.drudis.2023.103693","article-title":"Tweaking host immune responses for novel therapeutic approaches against Mycobacterium tuberculosis","volume":"28","author":"Roy","year":"2023","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.bioorg.2025.108718_bb0030","first-page":"1","article-title":"Exploring rhodanine linked enamine\u2013carbohydrazide derivatives as mycobacterial carbonic anhydrase inhibitors: design, synthesis, biological evaluation, and molecular docking studies","author":"Maddipatla","year":"2024","journal-title":"Arch. Pharm."},{"key":"10.1016\/j.bioorg.2025.108718_bb0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.micpath.2024.107074","article-title":"Advancements and challenges in tuberculosis drug discovery: A comprehensive. Overview","volume":"198","author":"Agnivesh","year":"2025","journal-title":"Microb. Pathog."},{"key":"10.1016\/j.bioorg.2025.108718_bb0040","doi-asserted-by":"crossref","first-page":"2264","DOI":"10.1021\/acs.jmedchem.3c01892","article-title":"Unraveling dilemmas and lacunae in the escalating drug resistance of Mycobacterium tuberculosis to Bedaquiline, Delamanid, and Pretomanid","volume":"67","author":"Negi","year":"2024","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108718_bb0045","series-title":"Exploration of 3-Aryl Pyrazole-Tethered Sulfamoyl Carboxamides as Carbonic Anhydrase Inhibitors Archiv der Pharmazie","author":"Ommi","year":"2023"},{"key":"10.1016\/j.bioorg.2025.108718_bb0050","doi-asserted-by":"crossref","first-page":"001695","DOI":"10.1099\/jmm.0.001695","article-title":"Unravelling the flexibility of Mycobacterium tuberculosis: an escape way for the Bacilli","volume":"72","author":"Sau","year":"2023","journal-title":"J. Med. Microbiol."},{"key":"10.1016\/j.bioorg.2025.108718_bb0055","doi-asserted-by":"crossref","DOI":"10.1002\/slct.202400320","article-title":"Small peptide conjugates of Benzothiazole-2-carboxylic acids targeting DprE1 against tuberculosis","volume":"9","author":"Samoon","year":"2024","journal-title":"ChemistrySelect"},{"key":"10.1016\/j.bioorg.2025.108718_bb0060","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1146\/annurev.micro.55.1.139","article-title":"Nonreplicating persistence of Mycobacterium tuberculosis Annu","volume":"55","author":"Wayne","year":"2001","journal-title":"Rev. Microbiol."},{"key":"10.1016\/j.bioorg.2025.108718_bb0065","doi-asserted-by":"crossref","first-page":"3478","DOI":"10.1002\/anie.201800260","article-title":"Small molecules targeting Mycobacterium Tuberculosis type II NADH dehydrogenase exhibit Antimycobacterial activity","volume":"57","author":"Harbut","year":"2018","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.bioorg.2025.108718_bb0070","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1039\/D3MD00587A","article-title":"Cytochrome Bd oxidase: an emerging anti-tubercular drug target","volume":"15","author":"Saha","year":"2024","journal-title":"RSC Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108718_bb0075","first-page":"70","article-title":"Tuberculosis - metabolism and respiration in the absence of growth Nat","volume":"3","author":"Boshoff","year":"2005","journal-title":"Rev. Microbiol."},{"key":"10.1016\/j.bioorg.2025.108718_bb0080","series-title":"Drugs and a Methodological Compendium: From Bench to Bedside","first-page":"357","article-title":"Perspectives on anti-tuberculosis drug discovery","author":"Sau","year":"2023"},{"key":"10.1016\/j.bioorg.2025.108718_bb0085","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/s10096-023-04663-0","article-title":"Exploring and exploiting the host cell autophagy during Mycobacterium tuberculosis infection","volume":"42","author":"Nagdev","year":"2023","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"10.1016\/j.bioorg.2025.108718_bb0090","article-title":"Inhibiting Mycobacterium tuberculosis within and without Philos","volume":"371","author":"Cole","year":"2016","journal-title":"Trans. R. Soc."},{"key":"10.1016\/j.bioorg.2025.108718_bb0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2021.114906","article-title":"Screening approaches and therapeutic targets: the two driving wheels of tuberculosis drug discovery","volume":"197","author":"Perveen","year":"2022","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bioorg.2025.108718_bb0100","doi-asserted-by":"crossref","first-page":"2062","DOI":"10.1128\/iai.64.6.2062-2069.1996","article-title":"An in vitro model for sequential study of shift down of Mycobacterium tuberculosis through two stages of nonreplicating persistence","volume":"64","author":"Wayne","year":"1996","journal-title":"Infect. Immun."},{"key":"10.1016\/j.bioorg.2025.108718_bb0105","doi-asserted-by":"crossref","first-page":"11479","DOI":"10.1073\/pnas.1407034111","article-title":"An obligately aerobic soil bacterium activates fermentative hydrogen production to survive reductive stress during hypoxia proc","volume":"111","author":"Berney","year":"2014","journal-title":"Natl. Acad. Sci."},{"key":"10.1016\/j.bioorg.2025.108718_bb0110","doi-asserted-by":"crossref","first-page":"11945","DOI":"10.1073\/pnas.0711697105","article-title":"The protonmotive force is required for maintaining ATP homeostasis and viability of hypoxic, nonreplicating Mycobacterium tuberculosis","volume":"105","author":"Rao","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.bioorg.2025.108718_bb0115","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1046\/j.1365-2958.2002.02779.x","article-title":"Evaluation of a nutrient starvation model of Mycobacterium tuberculosis persistence by gene and protein expression profiling","volume":"43","author":"Betts","year":"2002","journal-title":"Mol. Microbiol."},{"key":"10.1016\/j.bioorg.2025.108718_bb0120","article-title":"Role of transcription termination factor rho in anti-tuberculosis drug discovery drug","volume":"28","author":"Kumar","year":"2023","journal-title":"Discov. Today"},{"key":"10.1016\/j.bioorg.2025.108718_bb0125","series-title":"New mutations in the mycobacterial ATP synthase: New insights into the binding of the diarylquinoline TMC207 to the ATP synthase C-ring structure chemotherapy","first-page":"2326","volume":"56","author":"Segala","year":"2012"},{"key":"10.1016\/j.bioorg.2025.108718_bb0130","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1126\/science.1106753","article-title":"Diarylquinoline drug active on the ATP synthase of Mycobacterium Tuberculosis","volume":"307","author":"Andries","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.bioorg.2025.108718_bb0135","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1021\/ml300134b","article-title":"Quinolinyl pyrimidines: potent inhibitors of NDH-2 as a novel class of anti-TB agents","volume":"3","author":"Shirude","year":"2012","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2025.108718_bb0140","doi-asserted-by":"crossref","first-page":"16651","DOI":"10.1021\/acs.jmedchem.2c01493","article-title":"Tricyclic SpiroLactams kill mycobacteria in vitro and in vivo by inhibiting type II NADH dehydrogenases","volume":"65","author":"Dam","year":"2022","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108718_bb0145","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1038\/ncomms2898","article-title":"Mycobacterium tuberculosis is extraordinarily sensitive to killing by a vitamin C-induced Fenton reaction","volume":"4","author":"Vilch\u00e8ze","year":"2013","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bioorg.2025.108718_bb0150","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/mBio.00272-17","article-title":"Targeting energy metabolism in Mycobacterium tuberculosis, a new paradigm in antimycobacterial drug discovery","volume":"8","author":"Bald","year":"2017","journal-title":"mBio"},{"key":"10.1016\/j.bioorg.2025.108718_bb0155","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S0076-6879(08)04417-0","article-title":"Chapter 17 Type II NADH: quinone oxidoreductases of Plasmodium falciparum and Mycobacterium tuberculosis kinetic and high-throughput assays","volume":"456","author":"Fisher","year":"2009","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.bioorg.2025.108718_bb0160","series-title":"Roles of the two types II NADH dehydrogenases in the survival of Mycobacterium tuberculosis in vitro Gene","first-page":"110","volume":"550","author":"Awasthy","year":"2014"},{"key":"10.1016\/j.bioorg.2025.108718_bb0165","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1046\/j.1365-2958.2003.03425.x","article-title":"Genes required for mycobacterial growth defined by high density mutagenesis","volume":"48","author":"Sassetti","year":"2003","journal-title":"Mol. Microbiol."},{"key":"10.1016\/j.bioorg.2025.108718_bb0170","doi-asserted-by":"crossref","DOI":"10.1021\/acsinfecdis.4c01005","article-title":"Potential of Mycobacterium tuberculosis type II NADH-dehydrogenase in Antitubercular drug discovery","author":"Saha","year":"2025","journal-title":"ACS Infect Dis."},{"key":"10.1016\/j.bioorg.2025.108718_bb0175","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1021\/acsinfecdis.7b00275","article-title":"2-Mercapto-Quinazolinones as inhibitors of type II NADH dehydrogenase and Mycobacterium tuberculosis: structure-activity relationships, mechanism of action and absorption, distribution, metabolism, and excretion characterization","volume":"4","author":"Murugesan","year":"2018","journal-title":"ACS Infect Dis."},{"key":"10.1016\/j.bioorg.2025.108718_bb0180","doi-asserted-by":"crossref","first-page":"3699","DOI":"10.1021\/acsinfecdis.4c00710","article-title":"2-aryl-Benzoimidazoles as type II NADH dehydrogenase inhibitors of Mycobacterium tuberculosis","volume":"10","author":"Saha","year":"2024","journal-title":"ACS infect Dis."},{"key":"10.1016\/j.bioorg.2025.108718_bb0185","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1039\/D4MD00118D","article-title":"Antitubercular activity of 2-Mercaptobenzothiazole derivatives targeting Mycobacterium tuberculosis type II NADH dehydrogenase","volume":"15","author":"Saha","year":"2024","journal-title":"RSC Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108718_bb0190","doi-asserted-by":"crossref","first-page":"7371","DOI":"10.1021\/jo049056s","article-title":"Ortho-selective nucleophilic aromatic substitution reactions of Polyhaloanilines with potassium\/sodium O-ethyl xanthate: A convenient access to halogenated 2(3H)-Benzothiazolethiones","volume":"69","author":"Zhu","year":"2004","journal-title":"J. Organomet. Chem."},{"key":"10.1016\/j.bioorg.2025.108718_bb0195","doi-asserted-by":"crossref","first-page":"5836","DOI":"10.1021\/acs.orglett.7b02806","article-title":"Rapid access to a broad range of 6\u2032-substituted firefly luciferin analogues reveals surprising emitters and inhibitors","volume":"19","author":"Sharma","year":"2017","journal-title":"Org. Lett."},{"key":"10.1016\/j.bioorg.2025.108718_bb0200","doi-asserted-by":"crossref","first-page":"4898","DOI":"10.1021\/jm070564e","article-title":"Structure-activity relationships in the binding of chemically Derivatized CD4 to Gp120 from human immunodeficiency virus","volume":"50","author":"Xie","year":"2007","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108718_rf0205","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.tube.2017.10.008","article-title":"Screening of antitubercular compound library identifies novel ATP synthase inhibitors of Mycobacterium tuberculosis","volume":"108","author":"Kumar","year":"2018","journal-title":"Tuberculosis"},{"key":"10.1016\/j.bioorg.2025.108718_rf0210","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.ejmech.2014.02.017","article-title":"Sulfur rich 2-mercaptobenzothiazole and 1,2,3-triazole conjugates as novel antitubercular agents","volume":"76","author":"Mir","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108718_rf0215","first-page":"145","article-title":"(Z)-3-4-(benzo[d]thiazol-2-ylthio)phenyl-5-(substituted-benzylidene)-2- (pyridine-4-yl)thiazolidine-4-one as antitubercular agent: Their microwave assisted synthesis and molecular docking study","volume":"7","author":"Patel","year":"2017","journal-title":"Chem. Biol. Interface."},{"key":"10.1016\/j.bioorg.2025.108718_bb0210","doi-asserted-by":"crossref","first-page":"3320","DOI":"10.1021\/acsinfecdis.4c00415","article-title":"Development and evaluation of Bis-Benzothiazoles as a new class of Benzothiazoles targeting DprE1 as Antitubercular agents","volume":"10","author":"Samoon","year":"2024","journal-title":"ACS infect Dis."},{"key":"10.1016\/j.bioorg.2025.108718_bb0215","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jcc.21334","article-title":"AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading","volume":"31","author":"Trott","year":"2010","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.bioorg.2025.108718_bb0220","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/srep42717","article-title":"SwissADME: A free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small Molecules","volume":"7","author":"Daina","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bioorg.2025.108718_bb0225","doi-asserted-by":"crossref","first-page":"4066","DOI":"10.1021\/acs.jmedchem.5b00104","article-title":"PkCSM: predicting small-molecule pharmacokinetic and toxicity properties using graph-based signatures","volume":"58","author":"Pires","year":"2015","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108718_bb0230","first-page":"e02223","article-title":"GaMF1.39\u2019s antibiotic efficacy and its enhanced Antitubercular activity in combination with Clofazimine, Telacebec, ND-011992, or TBAJ-876 microbio","volume":"0","author":"Priya","year":"2023","journal-title":"Spectrum"},{"key":"10.1016\/j.bioorg.2025.108718_bb0235","doi-asserted-by":"crossref","first-page":"7426","DOI":"10.1073\/pnas.1706139114","article-title":"Exploiting the synthetic lethality between terminal respiratory oxidases to kill Mycobacterium tuberculosis and clear host infection","volume":"114","author":"Kalia","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.bioorg.2025.108718_bb0240","first-page":"1","article-title":"Imaging the NADH: NAD+ homeostasis for understanding the metabolic response of Mycobacterium to physiologically relevant stresses front","volume":"6","author":"Bhat","year":"2016","journal-title":"Cell. Infect. Microbiol."},{"key":"10.1016\/j.bioorg.2025.108718_bb0245","doi-asserted-by":"crossref","first-page":"10276","DOI":"10.1074\/jbc.M110.200501","article-title":"Reduction of Clofazimine by mycobacterial type 2 NADH: Quinone oxidoreductase: A pathway for the generation of bactericidal levels of reactive oxygen species","volume":"286","author":"Yano","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bioorg.2025.108718_bb0250","doi-asserted-by":"crossref","first-page":"7579","DOI":"10.1021\/acs.jmedchem.5c00049","article-title":"Structure of mycobacterial NDH-2 bound to a 2-Mercapto-Quinazolinone inhibitor","volume":"68","author":"Liang","year":"2025","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108718_bb0255","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1021\/jm000942e","article-title":"Fast calculation of molecular polar surface area as a sum of fragment-based contributions and its application to the prediction of drug transport properties","volume":"43","author":"Ertl","year":"2000","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108718_bb0260","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0169-409X(96)00423-1","article-title":"Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings","volume":"23","author":"Lipinski","year":"1997","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.bioorg.2025.108718_bb0265","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/513481a","article-title":"Chemistry: chemical con artists foil drug discovery","volume":"513","author":"Baell","year":"2014","journal-title":"Nature"}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004520682500598X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004520682500598X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T05:04:59Z","timestamp":1776920699000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S004520682500598X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":55,"alternative-id":["S004520682500598X"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2025.108718","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting drug-resistant tuberculosis: Thioacetamide-substituted benzothiazoles as bactericidal agents inhibiting type II NADH dehydrogenase","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2025.108718","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"108718"}}